No, Crashing The Stock Market With His Tariffs Definitely Was Not Part Of Donald Trump’s Plan All Along
Presidency by jump scare does not seem to be going so well.
4 Notable Health Tech Funding Announcements In March
Health tech companies made several major funding announcements in March. Here is a list of some of the biggest funding rounds.
Discover Powerful Negotiation And Exceptional Client Service With Foundation Insights
This new GenAI-powered deal point extraction tool provides big advantages in the negotiation process and beyond.
Cable Network Newsmax Soars Into Meme Stock Territory As Right-Wingers Scramble To Scam Their Peers
Welcome to hell, here's your meme stock prospectus.
Left-Leaning Tesla Protesters Have Arranged A Circular Firing Squad Around An Elon Musk Hologram
Backdating moral outrage is what got Democrats into the terrible situation they're now in in the first place.
Anne Wojcicki Had A Fully Financed Plan To Take 23andMe Private. Then It Fell Apart.
A month before 23andMe’s bankruptcy filing, CEO Anne Wojcicki had a fully financed proposal to take the genetic testing company private. The financing fell apart, and a series of alternative proposals by Wojcicki did not result in a deal.
Hinge Health Is Going Public. Is It Wise?
Amid the market volatility and intense macroeconomic uncertainty, is it wise for Hinge Health to test the public markets?
Thomson Reuters Editors + Law-Based AI: Why The Sum Is Greater Than The Parts
Practical Law's ‘Dynamic Tool Set’ application allows you to unleash the power of an army of attorney-experts while leveraging state-of-the-art gen AI.
Last-Minute Tax Planning Strategies For Small Law Firm Owners: There’s Still Time For 2024
You still have time to make a significant impact on your tax situation and long-term financial health.
Workers Are Not ‘Waste’ And Firing Feds Definitely Will Not Lower Prices Or Reduce The Deficit
Apparently forgetting that it is not opposite day, almost everything Trump is trying to do will raise, not lower, prices for consumers.
How Can Startups Navigate The Difficult Funding Environment
Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs navigating a tough funding environment.
Perhaps The Greatest Stock Market Correction Ever, Truly Terrific, Remember To Thank Your FAVORITE PRESIDENT!
A 15% drop here, a 15% drop there, and soon you're talking real problems.
How You Can Take Control Of Your Firm’s Financial Future
Roadblocks to data-driven business management are falling, and a better bottom line awaits.
Walgreens To Be Acquired By Sycamore Partners: Where Did The Retail Giant Go Wrong?
This comes after the company has faced increased competition from online retailers like Amazon. It remains to be seen, however, if Walgreens will perform better under Sycamore Partners.
Citizenship For Sale: Trump’s $5M ‘Gold Card’ Visa Seems Designed To Install A Rich Foreign Overclass
Let's Make America Victorian England Again!
5 Notable Health Tech Funding Announcements In February
Health tech companies made several major funding announcements in February. Here is a list of some of the biggest funding rounds.
KPMG Becomes The First Member Of The Big Four To Open US Law Firm
Wave goodbye to Biglaw, and say hello to Big Four Law!
Cash-Strapped Gene Therapy Firm Bluebird Bio Agrees To Acquisition By Private Equity
Carlyle and SK Capital Partners are buying beleaguered gene therapy biotech Bluebird Bio for about $29 million. Meanwhile, Pfizer continued the culling of its gene therapies with the discontinuation of Beqvez for hemophilia B.